ETF Holdings Breakdown of CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

News associated with CRL

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 09:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 07:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 18:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 08:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 09:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 08:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 09:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 08:58:52
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Cetera Investment Advisers
Cetera Investment Advisers reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.9% in the 4th quarter, HoldingsChannel reports. The firm owned 9,004 shares of the medical research company’s stock after selling 1,099 shares during the quarter. Cetera Investment Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-05-21 07:44:54
Baird Financial Group Inc. Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Baird Financial Group Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 67.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,592 shares of the medical research company’s stock after selling 5,494 shares during […] - 2025-05-16 08:31:13
1,160 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Algert Global LLC
Algert Global LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,160 shares of the medical research company’s stock, valued at approximately $214,000. Other hedge funds and other […] - 2025-05-14 09:16:51
Charles River Laboratories International (NYSE:CRL) Shares Gap Up After Earnings Beat
Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $115.41, but opened at $141.03. Charles River Laboratories International shares last traded at $134.46, with a volume of 1,274,674 shares […] - 2025-05-08 06:12:48
Insider Buying: Creightons Plc (LON:CRL) Insider Purchases 15,000 Shares of Stock
Creightons Plc (LON:CRL – Get Free Report) insider Jemima Bird purchased 15,000 shares of the stock in a transaction dated Friday, May 2nd. The shares were acquired at an average price of GBX 34 ($0.45) per share, with a total value of £5,100 ($6,780.11). Jemima Bird also recently made the following trade(s): On Monday, March […] - 2025-05-08 05:19:10
S&P 500 Movers: MRNA, CRL
In early trading on Wednesday, shares of Charles River Laboratories International topped the list of the day's best performing components of the S&P 500 index, trading up 19.9%. Year to date, Charles River Laboratories International has lost about 25.1% of its value. And t - 2025-05-07 14:19:08
Mariner LLC Sells 427 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Mariner LLC lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 19,648 shares of the medical research company’s stock after selling 427 shares during the period. Mariner LLC’s holdings in Charles River […] - 2025-04-22 08:48:52
Federated Hermes Inc. Sells 42,039 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 94.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,397 shares of the medical research company’s stock after selling 42,039 shares during the period. Federated Hermes Inc.’s holdings […] - 2025-04-18 07:57:07
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 29.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,445 shares of the medical research company’s stock after selling […] - 2025-04-15 08:20:53
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lowered by Orion Portfolio Solutions LLC
Orion Portfolio Solutions LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 57.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,390 shares of the medical research company’s stock after selling 1,847 shares during the period. […] - 2025-04-10 08:44:52
JPMorgan Chase & Co. Has $85.32 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
JPMorgan Chase & Co. reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 462,170 shares of the medical research company’s stock after selling 20,575 shares during […] - 2025-04-04 08:23:08
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Corebridge Financial Inc.
Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,108 shares of the medical research company’s stock after selling 706 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-02 08:27:11
Jemima Bird Buys 35,211 Shares of Creightons Plc (LON:CRL) Stock
Creightons Plc (LON:CRL – Get Free Report) insider Jemima Bird acquired 35,211 shares of Creightons stock in a transaction dated Monday, March 31st. The stock was bought at an average price of GBX 28 ($0.36) per share, with a total value of £9,859.08 ($12,746.06). Creightons Price Performance LON CRL opened at GBX 28.56 ($0.37) on […] - 2025-04-02 05:16:52
Commonwealth Equity Services LLC Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Commonwealth Equity Services LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 14.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,853 shares of the medical research company’s stock after selling 1,932 shares during the quarter. […] - 2025-03-28 07:54:50
Corient Private Wealth LLC Has $1.49 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Corient Private Wealth LLC reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 32.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,082 shares of the medical research company’s stock after selling 3,876 shares during […] - 2025-03-26 09:12:55
Charles River Laboratories International (NYSE:CRL) Cut to Neutral at The Goldman Sachs Group
The Goldman Sachs Group downgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a buy rating to a neutral rating in a report issued on Friday, MarketBeat Ratings reports. They currently have $170.00 price objective on the medical research company’s stock, down from their prior price objective of $190.00. Several other equities […] - 2025-03-24 07:00:43
M&T Bank Corp Buys 245 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
M&T Bank Corp increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 12.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,246 shares of the medical research company’s stock after buying an additional 245 shares […] - 2025-03-14 08:08:57
Raymond James Financial Inc. Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)
Raymond James Financial Inc. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 231,720 shares of the medical research company’s stock, valued at approximately $42,776,000. A number of other large investors have also added to or reduced their stakes in […] - 2025-03-13 08:35:38
Assetmark Inc. Has $1.80 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Assetmark Inc. grew its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5,099.5% during the 4th quarter, Holdings Channel reports. The firm owned 9,775 shares of the medical research company’s stock after purchasing an additional 9,587 shares during the quarter. Assetmark Inc.’s holdings in Charles River Laboratories International were worth $1,804,000 […] - 2025-03-11 08:20:57
Charles Schwab Investment Management Inc. Boosts Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 552,975 shares of the medical research company’s stock after acquiring an additional […] - 2025-03-10 08:44:49
1,382 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by QRG Capital Management Inc.
QRG Capital Management Inc. bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 1,382 shares of the medical research company’s stock, valued at approximately $255,000. Other hedge funds have also added to or reduced their stakes in the […] - 2025-03-07 09:30:55
Charles River Laboratories International, Inc. (NYSE:CRL) Receives $198.36 Consensus Price Target from Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average recommendation of “Hold” from the sixteen brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and one has given a buy rating to the company. The […] - 2025-03-07 08:38:58

CRL institutional holdings

The following institutional investment holdings of CRL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-26 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 118,580USD 17,975,542
2025-06-26 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 118,580USD 17,975,542
2025-06-26 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 118,580USD 17,975,542
2025-02-27 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 68,228USD 11,249,433 -1.9%
2025-02-27 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 10,092 -0.2%USD 1,663,969 -2.1%
2025-06-26 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 18,651USD 2,827,305
2025-02-27 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 8,869USD 1,462,321 -1.9%
2025-02-27 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 12,805 -0.1%USD 2,111,288 -2.0%
2025-02-27 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 12,805 -0.1%USD 2,111,288 -2.0%
2025-02-27 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 12,805 -0.1%USD 2,111,288 -2.0%
2024-11-18 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 5,730 195.5%USD 1,074,375 212.4%
2024-11-18 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 5,730 195.5%USD 1,074,375 212.4%
2025-02-27 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 4,620USD 761,746 -1.9%
2025-06-26 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 7,888USD 1,021,303
2025-02-27 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 1,024USD 168,837 -1.9%
2025-02-27 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 1,024USD 168,837 -1.9%
2025-02-27 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 4,019USD 662,653 -1.9%
2025-02-27 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 4,019USD 662,653 -1.9%
2025-06-26 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 62,290USD 9,442,541 0.9%
2025-06-26 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 62,290USD 9,442,541
2024-11-12 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 2,748 0.4%USD 559,313 -1.4%
2025-06-26 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 22,905USD 3,472,169 0.9%
2025-06-26 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 22,905USD 3,472,169
2025-02-27 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 1,806USD 297,773 -1.9%
2025-02-27 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 1,166USD 192,250 -1.9%
2025-06-26 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 60,802USD 9,216,975
2025-02-27 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 994USD 163,891 -1.9%
2024-11-12 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 1,272USD 274,676
2025-06-26 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 1,154 0.9%USD 127,378 1.0%
2025-06-26 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 794USD 120,362
2025-02-27 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 267USD 34,861 -1.3%
2025-02-27 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 1,706USD 281,285 -1.9%
2025-02-27 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 4,790USD 789,775 -1.9%
2025-06-26 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 391USD 59,272
2025-02-27 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 9USD 1,484 -1.9%
2025-02-27 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 9USD 1,484 -1.9%
2025-02-27 IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist)) 7USD 1,154 -1.9%
2025-02-27 IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc)) 7USD 1,154 -1.9%
2025-02-27 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 8,869USD 1,462,321 -1.9%
2024-11-08 IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc)) 958USD 206,344 2.4%
2025-06-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 31,642USD 4,796,611
2024-12-10 IE00B3VWMM18 (iShares MSCI EMU Small Cap UCITS) 96,424EUR 1,860,983 1.2%
2025-06-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 23,866USD 3,617,847
2025-06-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,146USD 173,722
Total =1,149,950 USD 166,876,931
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.